Latest NewsJun 18, 2025HiFiBiO Therapeutics to Present Preclinical Data of Three Leading I&I Programs at the 2025 Annual Meeting of the Federation of Clinical Immunology SocietiesAll Filter By: Year20252024202320222021202020192018201720162015May 24, 2024HiFiBiO Therapeutics to Present Phase 1 Clinical Trial Data for Two Novel Immuno-Oncology Agonists at the 2024 Annual Meeting of the American Society of Clinical OncologyApr 17, 2024EY Announces Liang Schweizer of HiFiBiO Therapeutics as an Entrepreneur Of The Year® 2024 New England Award FinalistApr 16, 2024HiFiBiO Therapeutics Receives Grant to Research Long COVID and ME/CFS in Collaboration with UMass Chan Medical SchoolApr 7, 2024HiFiBiO Therapeutics Presents Two Posters at the 2024 American Association for Cancer Research Annual MeetingMar 21, 2024HiFiBiO Therapeutics to Present at 2024 American Association for Cancer Research Annual Meeting< 1 2 3 4 … 17 >
